Infectious disease Clinical Trials
Recruiting infectious disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat infectious disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting infectious disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting infectious disease trials
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU
Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
Intervention to Reduce Implicit Bias in Pharmacies
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
PrEPwise Pilot Among Black Women in Eastern Virginia
Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior
Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya
HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria
The Extended Study of Prevalence of Infection in Intensive Care IV
Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care
Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics
Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms
Decision Support Tool to Integrate PrEP Into Emergency Departments
Biological Effects of Hemoadsorption in Septic Shock
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
Improving HIV Prevention and Substance Use Post-Sexual Assault Services
Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress
Optimizing Implementation of Long Acting Injectable PrEP
Immune Dysregulation During Sepsis: A Natural History Cohort
Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
Implementation of PrEP Care Among Women in Family Planning Clinics
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
Fatigue in Long COVID
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia
Theoretically Informed Behavioral Intervention
Peer-led Community-based PrEP Delivery Among Youth in Brazil
People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles
Baricitinib Curative Repression of HIV-1
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and Botswana
Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)
Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs
PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men
Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection
EARLY-SARDS: Early AlveolaR Lung biologY Underling Sepsis-Associated ARDS
A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.
Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking
Ketogenic Approach to Restore Muscle in Older Patients With Community-Acquired Pneumonia - KARMA-P Trial
TelePharm PrEP/PEP
INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Developing an HIV Disclosure Intervention for Men in Uganda
Confidential Care and Adolescent HIV Testing
Development of a Multilevel HIV Prevention Intervention for the Emergency Department
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
HIV Testing in Community Health Center Dental Clinics
Harmonized Healing: Personalized Music Interventions to Address Chronic Pain in People Living With HIV
C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Evaluation of biomArkers for Quick SEpsis Diagnosis - ErASED Study
New trials in San Francisco, CA?
Pick a condition and we'll email you once a week when a new study starts recruiting in San Francisco, CA. Unsubscribe anytime.
Infectious disease clinical trials — common questions
Are infectious disease clinical trials free to join?
Yes. Participating in a infectious disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a infectious disease clinical trial?
Each infectious disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a infectious disease trial near me?
Use the location controls above. We'll show recruiting infectious disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many infectious disease trials are recruiting right now?
We're currently tracking roughly 469 recruiting infectious disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.